breast cancer - HR positive | ||
la/mBC - HR-positive - 1st line (L1) | la/mBC - HR-positive - 2nd line (L2) | |
ribociclib based treatment | ||
ribociclib plus endocrine therapy | MONALEESA-7 | |
ribociclib plus fulvestrant | MONALEESA-3 | |
ribociclib plus letrozole | MONALEESA-2 |